KOMBINATIONSBEHANDLUNG FÜR AUGENFIBROSE UND / ODER ANGIOGENESE

European patent · EP3784282 · In force

Register entry

Publication number
EP3784282
Application number
EP19720551
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 26, 2019
Published
Mar 3, 2021
Granted
Jul 2, 2025
Protection ends at the latest
Apr 25, 2039
Next annual fee due
Apr 30, 2027
IPC classes
A61K 39/395 (2006.01)
A61K 40/00 (2025.01)
A61P 43/00 (2006.01)
Priority
GB 201806918 27.04.2018
PCT application
PCT/EP2019/060772 26.04.2019
PCT publication
WO2019/207122 31.10.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 18, 2026

    Change

    Published in Swissreg on 18.05.2026

  2. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  3. Jul 2, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 02.07.2025

Parties

Holder

Boehringer Ingelheim International GmbH

Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventor

COOK, Stuart Alexander

Singapore 068914, SG

SCHAEFER, Sebastian

Singapore 068914, SG

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.